44 results
424B5
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Prospectus supplement for primary offering
5:31pm
owners, but only because they agree to do so in their customer agreements or because they are legally required to do so. Investors who hold securities
8-K
EX-1.1
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:27pm
, street address, telephone number, email address, photograph, social security number, bank information, or customer or account number; (ii) any
424B5
ADIL
Adial Pharmaceuticals Inc
25 Jan 24
Prospectus supplement for primary offering
4:30pm
in their customer agreements or because they are legally required to do so. Investors who hold securities in street name will be indirect holders
8-K
EX-2.3
js3cza49
21 Sep 23
Entry into a Material Definitive Agreement
4:10pm
POS AM
xgmzlhzbmj74h7g6
24 Jun 22
Prospectus update (post-effective amendment)
5:11pm
POS AM
iddylxf
24 Jun 22
Prospectus update (post-effective amendment)
5:02pm
424B5
grv6qj 86jre
14 Feb 22
Prospectus supplement for primary offering
4:55pm
8-K
EX-10.1
1bzwn
9 Dec 21
Adial Announces Cary J. Claiborne, a Renowned Pharmaceutical Executive and Current Board Member, has Joined the Company as Chief Operating Officer
9:29am
8-K
advfkx2d vp
9 Dec 21
Adial Announces Cary J. Claiborne, a Renowned Pharmaceutical Executive and Current Board Member, has Joined the Company as Chief Operating Officer
9:29am
POS AM
h1fg j7kk4zno7
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
POS AM
eqfp ewqn97i1do
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
8-K
EX-10.1
cwq43
10 Dec 20
Entry into a Material Definitive Agreement
9:45am